UNIQUE MOLECULAR MARKERS IN HUMAN ENDOMETRIOSIS: IMPLICATIONS FOR DIAGNOSIS AND THERAPY
This paper explores unique molecular markers in endometriosis, a common, benign disease affecting reproductive-aged women and a significant cause of infertility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews endometriosis as a benign, sometimes progressive condition in which uterine-lining tissue spreads by local invasion or via blood vessels to distant sites, affecting an estimated 10–20% of women aged 30–40 and a substantial fraction of infertile women (30–45%). It frames the need for unique molecular markers by linking endometriosis prevalence and variability of symptoms to challenges in diagnosis and to potential avenues for therapy. A stated limitation is that the excerpt provides no original experimental data (it is presented as a review-style piece with limited bibliographic detail), so specific marker performance or validation criteria are not described here. This paper is centrally about endometriosis — it discusses the disease’s biology and the rationale for unique molecular markers to support diagnosis and therapy.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
681 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-15T06:33:26.365676+00:00